Market Cap 135.66M
Revenue (ttm) 0.00
Net Income (ttm) -40.21M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 296,000
Avg Vol 385,106
Day's Range N/A - N/A
Shares Out 12.26M
Stochastic %K 52%
Beta 2.69
Analysts Strong Sell
Price Target $42.33

Company Profile

Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally re...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 963 0100
Fax: 617 663 6085
Address:
500 River Ridge Drive, Norwood, United States
JarvisFlow
JarvisFlow Nov. 13 at 5:32 PM
RBC Capital has updated their rating for Corbus Pharmaceuticals ( $CRBP ) to Outperform with a price target of 53.
0 · Reply
birdmine
birdmine Nov. 13 at 4:25 PM
$CRBP hoping for 12 today.
0 · Reply
Hepacke
Hepacke Nov. 12 at 9:24 PM
0 · Reply
shlomiko
shlomiko Nov. 12 at 8:07 PM
0 · Reply
outlawinvestor1
outlawinvestor1 Nov. 12 at 6:13 PM
$CRBP let's see what yuval says about crb-913. 🧐 q3 vs q2 er re: 913. mad data should be completed.
0 · Reply
birdmine
birdmine Nov. 11 at 9:51 PM
$CRBP are they foregoing the earnings report for this quarter?
1 · Reply
birdmine
birdmine Nov. 10 at 9:43 PM
$CRBP fingers crossed for tomorrow!!!
0 · Reply
outlawinvestor1
outlawinvestor1 Nov. 6 at 5:14 PM
$CRBP tried to warn you all.
1 · Reply
birdmine
birdmine Nov. 6 at 4:11 PM
$CRBP how far is this shit going to fall before it eeks itself back up?!
1 · Reply
hichemben
hichemben Nov. 6 at 12:42 PM
$CRBP Is the ER's today at 8am Est?
1 · Reply
Latest News on CRBP
Corbus Pharmaceuticals Announces Pricing of Public Offering

Oct 31, 2025, 2:40 AM EDT - 16 days ago

Corbus Pharmaceuticals Announces Pricing of Public Offering


Corbus Pharmaceuticals Announces Proposed Public Offering

Oct 30, 2025, 4:31 PM EDT - 17 days ago

Corbus Pharmaceuticals Announces Proposed Public Offering


Corbus: Ability To Have Best-In-Class Nectin-4 Targeting Drug

Jan 30, 2024, 7:13 AM EST - 1 year ago

Corbus: Ability To Have Best-In-Class Nectin-4 Targeting Drug


JarvisFlow
JarvisFlow Nov. 13 at 5:32 PM
RBC Capital has updated their rating for Corbus Pharmaceuticals ( $CRBP ) to Outperform with a price target of 53.
0 · Reply
birdmine
birdmine Nov. 13 at 4:25 PM
$CRBP hoping for 12 today.
0 · Reply
Hepacke
Hepacke Nov. 12 at 9:24 PM
0 · Reply
shlomiko
shlomiko Nov. 12 at 8:07 PM
0 · Reply
outlawinvestor1
outlawinvestor1 Nov. 12 at 6:13 PM
$CRBP let's see what yuval says about crb-913. 🧐 q3 vs q2 er re: 913. mad data should be completed.
0 · Reply
birdmine
birdmine Nov. 11 at 9:51 PM
$CRBP are they foregoing the earnings report for this quarter?
1 · Reply
birdmine
birdmine Nov. 10 at 9:43 PM
$CRBP fingers crossed for tomorrow!!!
0 · Reply
outlawinvestor1
outlawinvestor1 Nov. 6 at 5:14 PM
$CRBP tried to warn you all.
1 · Reply
birdmine
birdmine Nov. 6 at 4:11 PM
$CRBP how far is this shit going to fall before it eeks itself back up?!
1 · Reply
hichemben
hichemben Nov. 6 at 12:42 PM
$CRBP Is the ER's today at 8am Est?
1 · Reply
birdmine
birdmine Nov. 5 at 9:45 PM
$CRBP man, I hate this stock so much. First sign of green, I’m out!!!
1 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 5 at 4:06 PM
0 · Reply
Quantumup
Quantumup Nov. 4 at 12:33 PM
Guggenheim⬆️ $PYXS's PT to $7 from $5, reiterated at a Buy, and said, PYXS' planned 4Q25 MICVO phase 1 data update is now going to be more robust and answer important investor questions about its competitive positioning in HNSCC. $MRK $CRBP Guggenheim went on to say:
0 · Reply
birdmine
birdmine Nov. 3 at 6:32 PM
$CRBP https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3WF1DD:0-corbus-pharmaceuticals-holdings-inc-expected-to-post-a-loss-of-1-71-a-share-earnings-preview/
0 · Reply
birdmine
birdmine Nov. 3 at 4:25 PM
$CRBP so, earnings have been moved up to Wednesday?
0 · Reply
birdmine
birdmine Nov. 2 at 11:36 PM
$CRBP I’m afraid to see what tomorrow brings!!
1 · Reply
SqueezeChronometer
SqueezeChronometer Nov. 2 at 10:48 AM
Next major retail squeeze candidate right here $JZXN $PHUN $CRBP $LPSN
0 · Reply
ChessGM
ChessGM Nov. 2 at 12:52 AM
$CRBP "Heads up alert! Only two days until Upcoming earnings on Monday, 11/3/2025 for $CRBG Bearish (2.5) Corebridge Financial, Inc. (CRBG) is currently facing a challenging landscape, as indicated by the recent developments surrounding its financial outlook and leadership changes. The resignation of CFO Elias Habayeb, effective April 2026, raises concerns about stability during a critical period, particularly as the company prepares to report its Q3 earnings. Analysts are projecting a decline in earnings, reflecting a lack of confidence in the company’s ability to meet or exceed previous performance metrics. The trailing P/E ratio of 8.64 and a forward P/E of 5.99 suggest that the stock is undervalued compared to industry peers, yet this valuation does not seem to translate into positive investor sentiment, especially given the modest reduction in the consensus price target from $40.23 to $39.85. Additionally, the recent strategic partnership with Allstate Financial Services could enhance distribution and market reach, but the overall sentiment remains cautious as the company navigates operational challenges. In terms of financial metrics, Corebridge's earnings per share (EPS) growth is under scrutiny, with expectations pointing towards a decline, which could further pressure the stock price. Revenue forecasts indicate a tempered outlook, as analysts balance operational strength against the backdrop of broader market uncertainties. Comparatively, while Corebridge's valuation metrics suggest potential for recovery, the current sentiment and market conditions do not favor a bullish outlook. Looking ahead, Corebridge's upcoming earnings report on November 3, 2025, is anticipated with caution. Historical performance has shown volatility, and the current analyst consensus estimates reflect a bearish sentiment, with expectations of declining earnings. This could have a significant impact on the stock, particularly if the results fall short of expectations. The overall performance of the insurance and financial services sector has been mixed, with some companies outperforming while others struggle, further complicating Corebridge's positioning in the market. Overall, the combination of leadership changes, declining earnings expectations, and cautious analyst sentiment suggests that investors should approach CRBG with caution in the near term. - Funds were net sellers of $CRBG during the previous reporting quarter. - Funds with large holdings in $CRBG include: - Canada Pension , MV: $139MM. Fund Rank: 78% - Basswood Capital Management LLC, MV: $15MM. Fund Rank: 69% basswoodpartners.com - Arbiter Partenrs Capital Management LLC, MV: $7MM. Fund Rank: 86% www.arbiterpartners.net - Last 10 days performance: 2% - Last 30 days performance: 0% - Last 90 days performance: -5% Some of the latest news articles: - Title: Corebridge Financial Announces Chief Financial Officer Transition Publication Date: 10/31/2025 8:15:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/corebridge-financial-announces-chief-financial-201500544.html?.tsrc=rss - Title: Assurant (AIZ) Earnings Expected to Grow: Should You Buy? Publication Date: 10/28/2025 2:00:30 PM, Source: yahoo URL: https://finance.yahoo.com/news/assurant-aiz-earnings-expected-grow-140030502.html?.tsrc=rss - Title: Earnings Preview: Corebridge Financial (CRBG) Q3 Earnings Expected to Decline Publication Date: 10/27/2025 2:00:10 PM, Source: yahoo URL: https://finance.yahoo.com/news/earnings-preview-corebridge-financial-crbg-140010019.html?.tsrc=rss - Title: Corebridge Financial Elects Tomohiro Yao to Board of Directors Publication Date: 10/23/2025 8:15:00 PM, Source: yahoo URL: https://finance.yahoo.com/news/corebridge-financial-elects-tomohiro-yao-201500006.html?.tsrc=rss Follow us on stocktwits.com for more earnings alerts. Not a financial advice. Not a trading signal."
1 · Reply
outlawinvestor1
outlawinvestor1 Oct. 31 at 9:30 PM
$CRBP https://seekingalpha.com/article/4836558-corbus-pharmaceuticals-downgrade-to-hold-due-to-narrow-focus-window
0 · Reply
Jckemp3
Jckemp3 Oct. 31 at 8:16 PM
$CRBP little less than 5mil to go ....
0 · Reply
birdmine
birdmine Oct. 31 at 7:19 PM
$CRBP the only time this stock has loads of volume is when it’s dropping!!
0 · Reply
h8ster
h8ster Oct. 31 at 6:55 PM
$CRBP Love -25% dip days for bios like this!!! Time to start loading.
0 · Reply